首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

2078900

虛擬腫瘤學市場：按組件、癌症類型、應用、最終用戶和地區分類

Virtual Oncology Market, By Component, By Cancer Type, By Application, By End User, By Geography

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，虛擬腫瘤學市場規模將達到 55.9 億美元，到 2033 年將達到 179 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 18.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	55.9億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	18.10%	2033年市場規模預測：	179億美元

虛擬腫瘤學是醫療保健領域的新興方向，它利用科技提供遠距癌症治療和支援服務。這包括多種數位化解決方案，例如遠端醫療、虛擬會診、遠端監測和個人化治療方案。虛擬腫瘤學的目標是改善患者預後、擴大醫療服務的覆蓋範圍並提升患者的整體就醫體驗。

隨著科技進步和全球癌症發生率的上升，虛擬腫瘤學近年來備受關注。這種方法具有許多優勢，包括減少患者的旅行時間和費用、提高獲得專家諮詢的便利性以及遠端監測患者健康狀況的能力。此外，它還能根據每位患者的個別需求和偏好，提供更個人化的治療方案。

市場動態：

預計未來幾年虛擬腫瘤學市場將顯著成長。主要促進因素包括癌症發病率上升、遠距醫療服務需求不斷成長以及技術進步。此外，新冠疫情進一步加速了虛擬腫瘤學解決方案的普及，因為醫院和診所都致力於減少面對面就診並最大限度地降低感染風險。

然而，一些挑戰可能會阻礙市場成長。資料安全和病患隱私方面的擔憂，以及監管壁壘，都對市場參與者構成重大障礙。此外，熟練虛擬技術的醫療專業人員短缺，以及實施此類系統的高成本，也可能限制市場擴張。

儘管如此，虛擬腫瘤學市場為現有市場參與者和新進者都提供了許多機會。人工智慧 (AI) 和機器學習演算法在虛擬腫瘤學領域的日益普及，有望提升診斷、治療方案製定和病患監測的程度。此外，科技公司與醫療服務提供者之間旨在開發創新解決方案和提升病人參與的合作，預計將推動市場成長。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
此外，我們也根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球虛擬腫瘤學市場中主要公司的概況。
本研究涵蓋的主要公司包括 Flatiron Health、McKesson Corporation、Cerner Corporation、Koninklijke Philips NV、Siemens Healthcare Private Limited、Crisp、Varian Medical Systems, Inc.、Elekta AB、Accuray Incorporated、C-TAC Health、Oscar Health、NX Management, LLC、Epic, Inc.
本報告提供的見解將使行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份關於全球虛擬腫瘤學市場的報告旨在為各種行業相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球虛擬腫瘤市場分析中使用的各種策略矩陣來支持決策流程，從而從中受益。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 北非
- 南非
- 中非

第9章競爭情勢

Flatiron Health
McKesson Corporation
Cerner Corporation
Koninklijke Philips NV
Siemens Healthcare Private Limited
Crisp
Varian Medical Systems, Inc.
Elekta AB
Accuray Incorporated
C-TAC Health
Oscar Health
NXGN Management, LLC
Epic Systems Corporation
Optum, Inc
AI
CureMatch, Inc.
Oncora Medical

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI6446

Virtual Oncology Market is estimated to be valued at USD 5.59 Bn in 2026 and is expected to reach USD 17.90 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5.59 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.10%	2033 Value Projection:	USD 17.90 Bn

Virtual oncology is an emerging field in healthcare that utilizes technology to provide remote cancer care and support services. It encompasses various digital solutions such as telemedicine, virtual consultations, remote monitoring, and personalized treatment plans. The aim of virtual oncology is to improve patient outcomes, increase access to care, and enhance the overall patient experience.

With advancements in technology and the increasing prevalence of cancer worldwide, virtual oncology has gained significant traction in recent years. This approach offers several benefits, including reduced travel time and costs for patients, improved access to expert opinions, and the ability to monitor patients' health remotely. It also allows for more personalized treatment options based on individual patient needs and preferences.

Market Dynamics:

The virtual oncology market is expected to witness substantial growth in the coming years, primarily driven by factors such as the increasing prevalence of cancer, the growing need for remote healthcare services, and advancements in technology. Additionally, the COVID-19 pandemic has further accelerated the adoption of virtual oncology solutions as hospitals and clinics focus on reducing in-person visits and minimizing the risk of infections.

However, there are certain challenges that may restrain market growth. Concerns regarding data security and patient privacy, along with regulatory barriers, pose significant hurdles for market players. Moreover, the lack of skilled healthcare professionals proficient in virtual technologies and the high costs associated with implementing such systems may limit the market's expansion.

Nevertheless, the virtual oncology market presents several opportunities for both existing and new market players. The increasing adoption of artificial intelligence (AI) and machine learning algorithms in virtual oncology can help improve diagnosis, treatment planning, and patient monitoring. Additionally, collaborations between technology companies and healthcare providers to develop innovative solutions and enhance patient engagement are expected to drive market growth.

Key Features of the Study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global virtual oncology market based on parameters such as company highlights, product portfolio, key highlights, financial performance, and strategies.
Key companies covered in this study include Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc, Orchestrate.AI, CureMatch, Inc., Oncora Medical
Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics.
The global virtual oncology market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders will benefit from the various strategy matrices used in analyzing the global virtual oncology market, which will aid in decision-making processes.

Virtual Oncology Market Segmentation:

Virtual Oncology Market, By Component (Revenue, USD Bn, 2021 - 2033)
Software
Service
Hardware
Virtual Oncology Market, By Cancer Type (Revenue, USD Bn, 2021 - 2033)
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Others (Pancreatic, Ovarian etc.)
Virtual Oncology Market, By Application (Revenue, USD Bn, 2021 - 2033)
Precision Medicine
Patient Care Management
Research & Development
Clinical Trials
Diagnosis & Treatment Decision Making
Data Management
Others (Billing Management, Regulatory Compliance etc.)
Virtual Oncology Market, By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals & Diagnostic Imaging Centers
Academic Institutions & Research Centers
Pharma & Biotech Companies
Contract Research Organizations (CROs)
Others (Reference Laboratories, Pharmacies etc.)
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Top companies in Virtual Oncology Market:
Flatiron Health
McKesson Corporation
Cerner Corporation
Koninklijke Philips N.V.
Siemens Healthcare Private Limited
Crisp
Varian Medical Systems, Inc.
Elekta AB
Accuray Incorporated
C-TAC Health
Oscar Health
NXGN Management, LLC
Epic Systems Corporation
Optum, Inc
CureMatch, Inc.
Oncora Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Virtual Oncology, By Component
- Market Virtual Oncology, By Cancer Type
- Market Virtual Oncology, By Application
- Market Virtual Oncology, By End User
- Market Virtual Oncology, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Rising prevalence of cancer globally
- Restraints
  - Data privacy and security concerns
- Opportunities
  - Emerging markets exhibit significant growth potential
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Virtual Oncology Market , By Component, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Service
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Virtual Oncology Market , By Cancer Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others (Pancreatic, Ovarian etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

6. Virtual Oncology Market , By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Patient Care Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Research & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Clinical Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Diagnosis & Treatment Decision Making
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others (Billing Management, Regulatory Compliance etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Virtual Oncology Market , By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals & Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Academic Institutions & Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Pharma & Biotech Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Others (Reference Laboratories, Pharmacies etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Virtual Oncology Market , By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Bn)
  - North Africa
  - South Africa
  - Central Africa

9. Competitive Landscape

Flatiron Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cerner Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Crisp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Varian Medical Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Elekta AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
C-TAC Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oscar Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NXGN Management, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Epic Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Optum, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AI
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CureMatch, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oncora Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views